
Julia Ann Lawrence DO
Assistant Professor, Internal Medicine, Bowman Gray School of Medicine
Join to view full profile
S Hawthorne RdWinston-Salem, NC 27157
Phone+1 336-716-2255
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Julia Lawrence, DO is an oncologist in Winston-Salem, North Carolina. She is currently licensed to practice medicine in North Carolina and Louisiana. She is an Assistant Professor at Bowman Gray School of Medicine.
Education & Training
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1989 - 1993
NYIT College Of Osteopathic MedicineClass of 1989
Certifications & Licensure
LA State License 2005 - Present
NC State License 2006 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient EHR Suite, Epic Systems Corporation, 2013-2017
Publications & Presentations
PubMed
- 1 citationsPreferences for breast cancer survivorship care by rural/urban residence and age at diagnosisKathryn E. Weaver, Chandylen L Nightingale, Julia Lawrence, Jennifer W. Talton, Sally Hauser
Supportive Care in Cancer. 2020-08-01 - 4 citationsNational Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.Abigail R Gifford, Julia Lawrence, Laura D. Baker, Ernie P. Balcueva, Doug Case
Journal of Oncology Research. 2017-01-01 - 16 citationsAnalysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.Sarah V. Colonna, Ashantice K. Higgins, JoAnn Alvarez, Benjamin R. Saville, Julia Lawrence
Clinical Breast Cancer. 2016-06-01